Minimum Effective Volume of Ropivacaine 7.5 mg/ml for the Lateral and Sagittal Infraclavicular Brachial Plexus Block

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Lars Marius Ytrebo, University Hospital of North Norway
ClinicalTrials.gov Identifier:
NCT01493986
First received: December 14, 2011
Last updated: September 9, 2012
Last verified: September 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2012
  Primary Completion Date: June 2012 (Final data collection date for primary outcome measure)